SCHEMBL22305784

SCHEMBL22305784

Cn1ccc(C(=O)NCC(=O)Nc2nc(-c3ccc4ccc(=O)n(C)c4c3)cs2)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.43
▸ MAPT P10636 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ TRPA1 O75762 9/20 0.42
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ POLB P06746 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ABL1 P00519 1/20 0.39
▸ CLK1 P49759 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22290429 0.90 TRPA1 (0.41) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL31173245 0.90 TRPA1 (0.41) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL31173169 0.89 SMARCA2 (0.50) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22290278 0.89 SMARCA2 (0.50) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22290365 0.85 MAPT (0.47) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22305951 0.82 MAPT (0.55) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22305368 0.82 MAPT (0.49) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22306207 0.81 RAB9A (0.65) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL30315944 0.80 HDAC3 (0.47) RAB9AMAPTNPC1SMN1; SMN2LMNA
SCHEMBL22306345 0.80 ROCK2 (0.47) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160180-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 — — WO disclosed
Send feedback